Advanced Biological Marketing (ABM) announced today that the research and development department of ABM has filed a patent on Focused Microbial Diversity™. Focused Microbial Diversity (FMD) is the technique employed by ABM to research and develop microbials that will be used in ABM products. “The Focused Microbial Diversity “platform” allows ABM to screen a wide array of microbial strains in the lab for specific traits and characteristics that benefit the plant without engaging in massive field trials”, states Dan Custis, CEO of ABM.

ABM uses genomic technologies and high throughput phenotyping to identify elite strains for its Focused Microbial Diversity platform. Genes and gene sequences are identified that are predictive of exceptional performance in the field and used to assemble strain consortia providing broad spectrum benefits such as crop yield increases and stress resistances. Using these techniques ABM filters the wheat from the chaff, thus eliminating the need for field trials on no- or low-potential biologicals. “Over the last 14 years, every strain or strain combination that was brought to the field trial stage was released as a successful agricultural product”, states Custis. “These efficiencies allow ABM the flexibility to address growers’ needs without investing large amounts of time and money on large field trials of products with little chance for success. The superior strain characterization and genetics of Focused Microbial Diversity are what drive ABM’s biological products”.